跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Insuljack 30:70 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Insuljack 30:70
Approved
STANDARD
Insuljack 30:70
M.J. Biopharm Pvt., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bb5d60a7cce22490
Company
M.J. Biopharm Pvt., Ltd.
Type
Standard
Approval Details
Approval Id
bb5d60a7cce22490
Drug Approval Philippines Name
Insuljack 30:70
Product Name
Insuljack 30:70
Registration Number
BRP-074-03
Brand Name
Insuljack 30:70
Generic Name
Insulin Human (rDNA)
Dosage Form
Suspension for Injection (IM/SC) (30% Soluble Insulin Human/ 70% Isophane Insulin Human)
Dosage Strength
100 IU/mL
Manufacturer
M.J. Biopharm Pvt., Ltd.
Importer
PNF Pharmaceutical, Inc.
Distributor
Jackpharma Inc.
Issuance Date
26 December 2022
Expiry Date
23 February 2027
Pharmacologic Category
Antidiabetic Agents
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bb5d60a7cce22490
Type
Standard
Back to Philippines FDA Approvals